First Time Loading...

Myovant Sciences Ltd
NYSE:MYOV

Watchlist Manager
Myovant Sciences Ltd Logo
Myovant Sciences Ltd
NYSE:MYOV
Watchlist
Price: 26.98 USD -0.04% Market Closed
Updated: May 2, 2024

Myovant Sciences Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Myovant Sciences Ltd
Revenue Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Myovant Sciences Ltd
NYSE:MYOV
Revenue
$379.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$27m
CAGR 3-Years
37%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
£249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
£673.1m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%

Myovant Sciences Ltd
Revenue Breakdown

Breakdown by Geography
Myovant Sciences Ltd

Not Available

Breakdown by Segments
Myovant Sciences Ltd

Total Revenue: 231m USD
100%
Collaboration Agreement: 121.7m USD
52.7%
Amortization Of Upfront Payment: 83.9m USD
36.3%
Amortization Of Regulatory Milestone: 21.1m USD
9.1%
Revenue Recognized Upon Completion Of Delivery: 16.7m USD
7.2%
Show More
Show Less

See Also

What is Myovant Sciences Ltd's Revenue?
Revenue
379.1m USD

Based on the financial report for Dec 31, 2022, Myovant Sciences Ltd's Revenue amounts to 379.1m USD.

What is Myovant Sciences Ltd's Revenue growth rate?
Revenue CAGR 1Y
91%

Over the last year, the Revenue growth was 91%.